During the past decade, North Shore Private Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Shore Private Hospital" #1 sponsor was "Australasian Gastro-Intestinal Trials Group" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Ethicon, Inc." with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Shore Private Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Academic and Community Cancer Research United" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cancer International Research Group (CIRG)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "North Shore Private Hospital" are "Arthritis, Degenerative" (1 trials), "Breast Cancer" (1 trials), "Cutaneous Squamous Cell Carcinoma" (1 trials), "Gastro-Oesophageal Cancer" (1 trials) and "Glioblastoma Multiforme" (1 trials). Many other conditions were trialed in "North Shore Private Hospital" in a lesser frequency.

Most popular intervention types in "North Shore Private Hospital" are "Drug" (4 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cemiplimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Shore Private Hospital" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "North Shore Private Hospital". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in North Shore Private Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in North Shore Private Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".